simvastatin has been researched along with Mouth Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kou, Y; Li, M; Liu, B; Liu, H; Rong, X; Wang, C; Yang, P; Zhang, Y; Zhou, Q | 1 |
| Kurakula, M; Naveen, NR | 1 |
| Fan, Y; Gao, K; Luo, S; Sun, C; Wang, H; Wang, T; Xiao, Q; Zhang, L; Zhang, Z | 1 |
3 other study(ies) available for simvastatin and Mouth Neoplasms
| Article | Year |
|---|---|
Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
Topics: Animals; Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Kruppel-Like Transcription Factors; Mice; Mouth Neoplasms; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2023 |
In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.
Topics: Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Mouth Neoplasms; Nanoparticles; Particle Size; Simvastatin; Tongue | 2020 |
Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca
Topics: Anoctamin-1; Carcinoma, Squamous Cell; Cell Proliferation; Cells, Cultured; Down-Regulation; Gene Expression Regulation, Neoplastic; HaCaT Cells; Humans; Ion Channel Gating; Mouth Neoplasms; Neoplasm Proteins; Neoplasm Staging; Simvastatin | 2021 |